Carmen González‐Vela

Author

Marqués de Valdecilla University Hospital

Also Known As

C González-Vela, C. Gonzalez-Vela, C. Gonzalez‐Vela, C. González-Vela, C. González‐Vela, CARMEN GONZÁLEZ-VELA, Carmen Gonzalez-Vela, Carmen Gonzalez‐Vela, Carmen González-Vela, Carmen González‐Vela

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Marqués de Valdecilla University Hospital Instituto de Investigación Marqués de Valdecilla Universidad de Cantabria Fundación Marques de Valdecilla Hospital Sierrallana

About

Carmen González‐Vela is an author at Marqués de Valdecilla University Hospital specializing in medicine, rheumatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	784
2	Health Sciences	1	1	10
3	Public Health	1	1	14
4	Epidemiology	1	1	14
5	Gastroenterology	1	1	12

Carmen González‐Vela

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
PLCG1 mutations in cutaneous T-cell lymphomas José P. Vaqué, Gonzalo Goméz-López, V. Monsálvez, Blood	2014	225
Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients J. Loricera, Ricardo Blanco, José L. Hernández, Seminars in Arthritis and Rheumatism RheumatologyAutoimmune DiseaseVasculitisImmunologyMulticenter Open-label Study	2014	132
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients N. Vegas-Revenga, V. Calvo-Río, Marina Mesquida, American Journal of Ophthalmology Ocular DiseaseOphthalmologyAnti-il6-receptor TocilizumabImmunologyGlaucoma	2019	111
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro, Seminars in Arthritis and Rheumatism RheumatologyAutoimmune DiseaseVasculitisOpen-label Multicenter StudyImmunology	2019	105
Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica D. Prieto-Peña, I. Martínez‐Rodríguez, J. Loricera, Seminars in Arthritis and Rheumatism RheumatologyVasculitisPersistent Polymyalgia RheumaticaLarge Vessel VasculitisRheumatic Diseases	2018	102
Tocilizumab in refractory aortitis: study on 16 patients and literature review. J. Loricera, Ricardo Blanco, Santos Castañeda, PubMed Refractory AortitisVasculitisImmunodeficienciesImmunologyImmunotherapy	2014	93
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients Leyre Riancho‐Zarrabeitia, V. Calvo-Río, Ricardo Blanco, Seminars in Arthritis and Rheumatism Refractory UveitisRheumatologyAutoimmune DiseaseImmunologyClinical Dermatology	2015	88
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease J. L. Martín-Varillas, V. Calvo-Río, E. Beltrán, Ophthalmology Autoimmune DiseaseOphthalmologyImmunologyAdalimumab TherapyImmunotherapy	2018	65
Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review. J. Loricera, Ricardo Blanco, José L. Hernández, PubMed	2016	59
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features Arantza Onaindía, Santiago Montes‐Moreno, Socorro Marıá Rodríguez-Pinilla, Histopathology	2014	56

Page 1